Leonard Bell: Using Medicine to Change the World

Posted on January 17, 2012


Aside from tech, the pharmaceutical industry has grown tremendously in the past decade. This industry is a venue for innovation; new medications for all kinds of diseases are developed and discovered every day. Leonard Bell, founder of the biotech company Alexion, saw this as an opportunity.

Before entering the world of business, Bell was a practicing physician, Assistant Professor of Medicine and Pathology and co-Director of Yale University School of Medicine’s Program in Vascular Biology. He practiced and taught medicine for quite a number of years before deciding to start his own company, Alexion, in 1992. Fifteen years later, he managed to raise $800 million dollars which he used for research and development. All this money was put into good use. Under his direction, the company was able to create a drug which is a first of its kind.

Bell created the first FDA-approved drug called Soliris, recommended for patients with PNH. PNH is a rare and dangerous blood disease which causes red blood to break down at a faster rate. With this innovation, Bell managed to affect lives of millions afflicted with this disease.

Bell, also a notable leader in business and one of the smartest people in tech, plans to take his innovation to greater heights. Now that Soliris is an approved medication for PNH, he plans to explore other uses of the drug to benefit patients with other blood-related diseases. Bell is also looking into the possibility of Soliris as a    drug for kidney transplant patients.

Looking at Bell’s achievements, we can say that business does not have to be all about making money. Business is about innovation and helping others make the most out of their lives. In the field of biotech, Bell is definitely one innovator and business leader to be admired and emulated by other aspiring entrepreneurs.

Posted in: Entrepreneurs